News
Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...
Researchers identified a natural 'brake' within the innate immune system: the inhibitory receptor Siglec-E (SigE) and its human counterparts, Siglec-7 and Siglec-9. This receptor helps prevent ...
Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.
Current treatments to prevent organ transplant rejection focus mainly on suppressing T cells, part of the adaptive immune ...
How your immune system really ages — research shows aging brings adaptation not decline and reveals ways to maintain immune ...
REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of ...
You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...
In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...
1d
GlobalData on MSNBioVaxys and Sona partner to develop cancer therapeuticsBioVaxys Technology and Sona Nanotech have signed a research agreement to develop cancer therapeutics utilising the former’s ...
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...
Feeling run-down or catching every cold that comes your way? It might be time to check your vitamin intake. A strong immune ...
Some people may be more vulnerable to infections and illnesses than others and several factors can be to blame Here’s what a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results